-
Parkinson’s Researchers Team Up to Tackle Progressive Supranuclear Palsy
Parkinson’s Institute and Clinical Center and Retrotope have paired up to explore the therapeutic potential of the investigational agent RT001 in patients with progressive supranuclear palsy (PSP), a type of treatment-resistant Parkinson’s disease. Click here to learn more about this partnership and the work it seeks to accomplish.
Did you know about this collaboration? How do you think it will help those living with Parkinson’s disese? Share your thoughts below!
Sorry, there were no replies found.
Log in to reply.